Steven W. Andrews,Sean Aronow,James F. Blake,Barbara J. Brandhuber,James Collier,Adam Cook,Julia Haas,Yutong Jiang,Gabrielle R. Kolakowski,Elizabeth A. McFaddin,Megan L. McKenney,Oren T. McNulty,Andre
申请号：
US15860894
公开号：
US20180133207A1
申请日:
2018.01.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are compounds of the Formula I:or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X1, X2, X3, X4, Ring D, E, Ra, Rb, n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
